Engaged in advancing innovative solutions for large-scale market applications
Tel Aviv, Israel, March 03, 2022 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle (“EV”) and charging solutions, announced today that Polyrizon Ltd., a privately held company in which Medigus owns 37.03%, has added Prof. Nancy Agmon-Levin, expert in immunology, allergy, internal medicine, to its scientific advisory board.
Prof. Agmon- Levin is the Head of the Clinical Immunology, Angioedema and Allergy Unit, Lupus and Autoimmune Diseases Clinic at Sheba Medical Center. Prof. Agmon-Levin graduated from the Hadassah Medical School of the Hebrew University of Jerusalem and completed a fellowship in Clinical Immunology at the German Cancer Research Center (DKFZ), Heidelberg, Germany.
Prof. Agmon- Levin’s major fields of interest include autoimmune diseases (lupus and antiphospholipid syndrome), immune system diseases (urticaria, angioedema, immune deficiencies and Granulomatous Disease), allergies in children and adults, and immunotherapy. Prof. Agmon-Levin is a co-author of numerous scientific articles.
Prof. Agmon-Levin joins a scientific advisory board that already includes distinguished professors in the fields of biomaterials, drug delivery systems and nasal administrated products. The current composition of Polyrizon’s scientific advisory board members include:
Prof. Smadar Cohen – Distinguished Professor and Director of the Regenerative Medicine and Stem Cell Research Center at Ben Gurion University of the Negev.
Prof. Avi Schroeder – Targeted drug delivery and personalized medicine technologies expert. An associate professor and a member of the Wolfson Faculty of Chemical Engineering at the Technion Institution, Israel.
Prof. Fabio Sonvico – Specializes in the development of intranasal and pulmonary routes and products. Associate professor at the pharmacy department of the University of Parma, Italy.